Skip to content

Ensure Cardiac Resynchronization Therapy Study

Ensure Cardiac Resynchronization Therapy Study

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT00291564
Enrollment
430
Registered
2006-02-14
Start date
2004-05-31
Completion date
2006-02-28
Last updated
2007-12-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Heart Failure

Keywords

Observational, Heart Failure, Continuous Cardiac Resynchronization Therapy

Brief summary

The purpose of this study is to gather information on how doctors program particular settings on cardiac resynchronization therapy implantable cardiac defibrillators (CRT-Ds), to analyze how these settings affect the amount of cardiac resynchronization therapy (CRT) patients receive and to evaluate the therapy approach for converting abnormally fast heartbeats into normal heartbeats. There are no experimental devices or procedures involved in this study.

Interventions

Sponsors

Medtronic
CollaboratorINDUSTRY
Medtronic Cardiac Rhythm and Heart Failure
Lead SponsorINDUSTRY

Study design

Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patient is indicated for a Medtronic CRT-D system * Patient is willing to sign Permission for Access to and Use of Health Information form * Patient is willing and able to comply with follow-up visits through six months

Exclusion criteria

* Patient has a life expectancy of less than 6 months * Patient is participating in any concurrent study that could confound the results for either study

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026